1. Home
  2. DNTH vs SLSR Comparison

DNTH vs SLSR Comparison

Compare DNTH & SLSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • SLSR
  • Stock Information
  • Founded
  • DNTH 2015
  • SLSR 2018
  • Country
  • DNTH United States
  • SLSR Canada
  • Employees
  • DNTH N/A
  • SLSR N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • SLSR
  • Sector
  • DNTH Health Care
  • SLSR
  • Exchange
  • DNTH Nasdaq
  • SLSR NYSE
  • Market Cap
  • DNTH 711.2M
  • SLSR 581.3M
  • IPO Year
  • DNTH N/A
  • SLSR N/A
  • Fundamental
  • Price
  • DNTH $21.66
  • SLSR $3.61
  • Analyst Decision
  • DNTH Strong Buy
  • SLSR Strong Buy
  • Analyst Count
  • DNTH 9
  • SLSR 2
  • Target Price
  • DNTH $46.43
  • SLSR $7.50
  • AVG Volume (30 Days)
  • DNTH 285.9K
  • SLSR 58.9K
  • Earning Date
  • DNTH 11-07-2024
  • SLSR 02-09-2025
  • Dividend Yield
  • DNTH N/A
  • SLSR N/A
  • EPS Growth
  • DNTH N/A
  • SLSR N/A
  • EPS
  • DNTH N/A
  • SLSR N/A
  • Revenue
  • DNTH $5,366,000.00
  • SLSR N/A
  • Revenue This Year
  • DNTH $100.14
  • SLSR N/A
  • Revenue Next Year
  • DNTH N/A
  • SLSR N/A
  • P/E Ratio
  • DNTH N/A
  • SLSR N/A
  • Revenue Growth
  • DNTH 51.41
  • SLSR N/A
  • 52 Week Low
  • DNTH $14.82
  • SLSR $0.03
  • 52 Week High
  • DNTH $33.77
  • SLSR $0.19
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 45.12
  • SLSR 62.95
  • Support Level
  • DNTH $18.72
  • SLSR $3.46
  • Resistance Level
  • DNTH $28.65
  • SLSR $3.61
  • Average True Range (ATR)
  • DNTH 2.31
  • SLSR 0.16
  • MACD
  • DNTH -0.33
  • SLSR 0.02
  • Stochastic Oscillator
  • DNTH 32.14
  • SLSR 84.85

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About SLSR SOLARIS RESOURCES INC

Solaris Resources Inc is advancing a portfolio of copper and gold assets in the Americas, which includes a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru, and the La Verde joint venture project.

Share on Social Networks: